FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087793 [Registered on: 28/05/2025] Trial Registered Prospectively
Last Modified On: 27/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Unani
Other (Specify) [Hair care ]  
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Study to evaluate the effectiveness of an Unani Shampoo in the management of Dandruff  
Scientific Title of Study   A Randomized Contrlled Two arm Clinical Trial to Evaluate the Eficacy of a Compound Unani Formula in case of Dandruff 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr MEENAZ FATHIMA 
Designation  PG Scholar 
Affiliation  Government Nizamia Tibbi College and General Hospital 
Address  OPD 1 Room no. 1,PG Department of Moalejat, Government Nizamia Tibbi College and General Hospital charminar

Hyderabad
TELANGANA
500002
India 
Phone  7981830570  
Fax    
Email  drmeenazfathima1998@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S A KHADIR HUSSAINI 
Designation  Professor  
Affiliation  Government Nizamia Tibbi College and General Hospital 
Address  OPD 1 Room no. 1,PG Department of Moalejat, Government Nizamia Tibbi College and General Hospital charminar

Hyderabad
TELANGANA
500002
India 
Phone  9704888561  
Fax    
Email  sakhussaini@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S A KHADIR HUSSAINI 
Designation  Professor  
Affiliation  Government Nizamia Tibbi College and General Hospital 
Address  OPD 1 Room no. 1,PG Department of Moalejat, Government Nizamia Tibbi College and General Hospital charminar

Hyderabad
TELANGANA
500002
India 
Phone  9704888561  
Fax    
Email  sakhussaini@gmail.com  
 
Source of Monetary or Material Support  
Government Nizamia Tibbi College and General Hospital 
 
Primary Sponsor  
Name  Government Nizamia Tibbi College and General Hospital 
Address  Government Nizamia Tibbi College and General Hospital charminar Hyderabad Telangana 500002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr MEENAZ FATHIMA  Government Nizamia Tibbi College and General Hospital   OPD Room no 1 PG Department of Moalijat gen medicine Government Nizamia Tibbi College and General Hospital Charminar Hyderabad TELANGANA 500002 India Hyderabad TELANGANA
Hyderabad
TELANGANA 
7981830570

drmeenazfathima1998@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee (IEC), Government Nizamia Tibbbi College, Hyderabad   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L219||Seborrheic dermatitis, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  hair shampoo  Make shampoo Equal Quantities Preparation: - Take 10 grams of each of the following drugs: Nakhood, Baqila, Turmus, Khatmi, and Methi. use it to apply 2 times a week for 45day  
Comparator Agent  hair shampoo  Ketoconazole 2% shampoo twice a week for 45 days  
 
Inclusion Criteria  
Age From  13.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Both sexes
Age 13 to 50 years
Patients
Excoriation Pruritus Grading EPG
Adherent Scalp Flaking Score ASFS
with any signs and symptoms of
hazaz or Bafa Dandruff
 
 
ExclusionCriteria 
Details  Patients diagnosed with other scalp diseases
Patients who had received any systemic or topical antimycotic therapy within a month of the start of the study
Patients undergoing chemotherapy or radiotherapy
Immunocompromised patients 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Excoriation pruritus grading. (EPG)
Adherent Scalp Flaking Score (ASFS)
trying to bring the score below 7 
Within 45 days 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

ยท       Dandruff  also called pityriasis capitis or seborrheic dermatitis is a chronic scalp condition affecting over half the global population Recognized since ancient times it is referred to in Unani medicine as Hazaz or Bafa meaning scalp flakes and dryness It typically begins around or after puberty and is more common in males likely due to androgen involvement Dandruff can impact self esteem and social interactions due to its persistent and visible nature Its cause is multifactorial with the yeast Malassezia playing a key role by breaking down sebum and releasing fatty acids which irritate the scalp and lead to excessive flaking Conventional treatments may cause side effects like itching dryness and dermatitis limiting their use Unani literature offers alternative remedies One such formula was made into a shampoo and tested on albino rats showing no allergic reaction A clinical trial on humans is now planned to assess its safety and effectiveness

 
Close